Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.74SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.5.53SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3120.32Singapore
A.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDK.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.4.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.3.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.59SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BR.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CM.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBDSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BG.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.576SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.325SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.521SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.378SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.206SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.77SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HK.13.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HV.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBESYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.3.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.93 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.31.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GW.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HK.3.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-3120.32Singapore
BA.4.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BW.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.2.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used